Cite
HARVARD Citation
Visvanathan, S. et al. (2009). Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Annals of the rheumatic diseases. 68 (2), pp. 175-182. [Online].